Retinal ganglion cell-specific genetic regulation in primary open-angle glaucoma
Maciej Daniszewski,Anne Senabouth,Helena H Liang,Xikun Han,Grace E Lidgerwood,Damián Hernández,Priyadharshini Sivakumaran,Jordan E Clarke,Shiang Y Lim,Jarmon G Lees,Louise Rooney,Lerna Gulluyan,Emmanuelle Souzeau,Stuart L Graham,Chia-Ling Chan,Uyen Nguyen,Nona Farbehi,Vikkitharan Gnanasambandapillai,Rachael A McCloy,Linda Clarke,Lisa S Kearns,David A Mackey,Jamie E Craig,Stuart MacGregor,Joseph E Powell,Alice Pébay,Alex W Hewitt
DOI: https://doi.org/10.1016/j.xgen.2022.100142
2022-06-08
Abstract:To assess the transcriptomic profile of disease-specific cell populations, fibroblasts from patients with primary open-angle glaucoma (POAG) were reprogrammed into induced pluripotent stem cells (iPSCs) before being differentiated into retinal organoids and compared with those from healthy individuals. We performed single-cell RNA sequencing of a total of 247,520 cells and identified cluster-specific molecular signatures. Comparing the gene expression profile between cases and controls, we identified novel genetic associations for this blinding disease. Expression quantitative trait mapping identified a total of 4,443 significant loci across all cell types, 312 of which are specific to the retinal ganglion cell subpopulations, which ultimately degenerate in POAG. Transcriptome-wide association analysis identified genes at loci previously associated with POAG, and analysis, conditional on disease status, implicated 97 statistically significant retinal ganglion cell-specific expression quantitative trait loci. This work highlights the power of large-scale iPSC studies to uncover context-specific profiles for a genetically complex disease.